Global Age-related Macular Degeneration Market Insights and Forecast to 2028

Report ID: 1228166 | Published Date: May 2024 | No. of Page: 114 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Age-related Macular Degeneration Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Wet AMD
        1.2.3 Dry AMD
    1.3 Market by Application
        1.3.1 Global Age-related Macular Degeneration Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Drugstore
        1.3.3 Hospital
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Age-related Macular Degeneration Market Perspective (2017-2028)
    2.2 Age-related Macular Degeneration Growth Trends by Region
        2.2.1 Age-related Macular Degeneration Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Age-related Macular Degeneration Historic Market Size by Region (2017-2022)
        2.2.3 Age-related Macular Degeneration Forecasted Market Size by Region (2023-2028)
    2.3 Age-related Macular Degeneration Market Dynamics
        2.3.1 Age-related Macular Degeneration Industry Trends
        2.3.2 Age-related Macular Degeneration Market Drivers
        2.3.3 Age-related Macular Degeneration Market Challenges
        2.3.4 Age-related Macular Degeneration Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Age-related Macular Degeneration Players by Revenue
        3.1.1 Global Top Age-related Macular Degeneration Players by Revenue (2017-2022)
        3.1.2 Global Age-related Macular Degeneration Revenue Market Share by Players (2017-2022)
    3.2 Global Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Age-related Macular Degeneration Revenue
    3.4 Global Age-related Macular Degeneration Market Concentration Ratio
        3.4.1 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Revenue in 2021
    3.5 Age-related Macular Degeneration Key Players Head office and Area Served
    3.6 Key Players Age-related Macular Degeneration Product Solution and Service
    3.7 Date of Enter into Age-related Macular Degeneration Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Age-related Macular Degeneration Breakdown Data by Type
    4.1 Global Age-related Macular Degeneration Historic Market Size by Type (2017-2022)
    4.2 Global Age-related Macular Degeneration Forecasted Market Size by Type (2023-2028)
5 Age-related Macular Degeneration Breakdown Data by Application
    5.1 Global Age-related Macular Degeneration Historic Market Size by Application (2017-2022)
    5.2 Global Age-related Macular Degeneration Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Age-related Macular Degeneration Market Size (2017-2028)
    6.2 North America Age-related Macular Degeneration Market Size by Type
        6.2.1 North America Age-related Macular Degeneration Market Size by Type (2017-2022)
        6.2.2 North America Age-related Macular Degeneration Market Size by Type (2023-2028)
        6.2.3 North America Age-related Macular Degeneration Market Share by Type (2017-2028)
    6.3 North America Age-related Macular Degeneration Market Size by Application
        6.3.1 North America Age-related Macular Degeneration Market Size by Application (2017-2022)
        6.3.2 North America Age-related Macular Degeneration Market Size by Application (2023-2028)
        6.3.3 North America Age-related Macular Degeneration Market Share by Application (2017-2028)
    6.4 North America Age-related Macular Degeneration Market Size by Country
        6.4.1 North America Age-related Macular Degeneration Market Size by Country (2017-2022)
        6.4.2 North America Age-related Macular Degeneration Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Age-related Macular Degeneration Market Size (2017-2028)
    7.2 Europe Age-related Macular Degeneration Market Size by Type
        7.2.1 Europe Age-related Macular Degeneration Market Size by Type (2017-2022)
        7.2.2 Europe Age-related Macular Degeneration Market Size by Type (2023-2028)
        7.2.3 Europe Age-related Macular Degeneration Market Share by Type (2017-2028)
    7.3 Europe Age-related Macular Degeneration Market Size by Application
        7.3.1 Europe Age-related Macular Degeneration Market Size by Application (2017-2022)
        7.3.2 Europe Age-related Macular Degeneration Market Size by Application (2023-2028)
        7.3.3 Europe Age-related Macular Degeneration Market Share by Application (2017-2028)
    7.4 Europe Age-related Macular Degeneration Market Size by Country
        7.4.1 Europe Age-related Macular Degeneration Market Size by Country (2017-2022)
        7.4.2 Europe Age-related Macular Degeneration Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Age-related Macular Degeneration Market Size (2017-2028)
    8.2 Asia-Pacific Age-related Macular Degeneration Market Size by Type
        8.2.1 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Age-related Macular Degeneration Market Share by Type (2017-2028)
    8.3 Asia-Pacific Age-related Macular Degeneration Market Size by Application
        8.3.1 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Age-related Macular Degeneration Market Share by Application (2017-2028)
    8.4 Asia-Pacific Age-related Macular Degeneration Market Size by Region
        8.4.1 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Age-related Macular Degeneration Market Size (2017-2028)
    9.2 Latin America Age-related Macular Degeneration Market Size by Type
        9.2.1 Latin America Age-related Macular Degeneration Market Size by Type (2017-2022)
        9.2.2 Latin America Age-related Macular Degeneration Market Size by Type (2023-2028)
        9.2.3 Latin America Age-related Macular Degeneration Market Share by Type (2017-2028)
    9.3 Latin America Age-related Macular Degeneration Market Size by Application
        9.3.1 Latin America Age-related Macular Degeneration Market Size by Application (2017-2022)
        9.3.2 Latin America Age-related Macular Degeneration Market Size by Application (2023-2028)
        9.3.3 Latin America Age-related Macular Degeneration Market Share by Application (2017-2028)
    9.4 Latin America Age-related Macular Degeneration Market Size by Country
        9.4.1 Latin America Age-related Macular Degeneration Market Size by Country (2017-2022)
        9.4.2 Latin America Age-related Macular Degeneration Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Age-related Macular Degeneration Market Size (2017-2028)
    10.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type
        10.2.1 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Age-related Macular Degeneration Market Share by Type (2017-2028)
    10.3 Middle East & Africa Age-related Macular Degeneration Market Size by Application
        10.3.1 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Age-related Macular Degeneration Market Share by Application (2017-2028)
    10.4 Middle East & Africa Age-related Macular Degeneration Market Size by Country
        10.4.1 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Bayer HealthCare
        11.1.1 Bayer HealthCare Company Details
        11.1.2 Bayer HealthCare Business Overview
        11.1.3 Bayer HealthCare Age-related Macular Degeneration Introduction
        11.1.4 Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.1.5 Bayer HealthCare Recent Developments
    11.2 F. Hoffmann-La Roche
        11.2.1 F. Hoffmann-La Roche Company Details
        11.2.2 F. Hoffmann-La Roche Business Overview
        11.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Introduction
        11.2.4 F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.2.5 F. Hoffmann-La Roche Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Age-related Macular Degeneration Introduction
        11.3.4 Novartis Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.3.5 Novartis Recent Developments
    11.4 Regeneron Pharmaceuticals
        11.4.1 Regeneron Pharmaceuticals Company Details
        11.4.2 Regeneron Pharmaceuticals Business Overview
        11.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Introduction
        11.4.4 Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.4.5 Regeneron Pharmaceuticals Recent Developments
    11.5 Alcon
        11.5.1 Alcon Company Details
        11.5.2 Alcon Business Overview
        11.5.3 Alcon Age-related Macular Degeneration Introduction
        11.5.4 Alcon Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.5.5 Alcon Recent Developments
    11.6 Allergan
        11.6.1 Allergan Company Details
        11.6.2 Allergan Business Overview
        11.6.3 Allergan Age-related Macular Degeneration Introduction
        11.6.4 Allergan Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.6.5 Allergan Recent Developments
    11.7 Avalanche
        11.7.1 Avalanche Company Details
        11.7.2 Avalanche Business Overview
        11.7.3 Avalanche Age-related Macular Degeneration Introduction
        11.7.4 Avalanche Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.7.5 Avalanche Recent Developments
    11.8 Bausch+Lomb
        11.8.1 Bausch+Lomb Company Details
        11.8.2 Bausch+Lomb Business Overview
        11.8.3 Bausch+Lomb Age-related Macular Degeneration Introduction
        11.8.4 Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.8.5 Bausch+Lomb Recent Developments
    11.9 Gilead Sciences
        11.9.1 Gilead Sciences Company Details
        11.9.2 Gilead Sciences Business Overview
        11.9.3 Gilead Sciences Age-related Macular Degeneration Introduction
        11.9.4 Gilead Sciences Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.9.5 Gilead Sciences Recent Developments
    11.10 Iconic Therapeutics
        11.10.1 Iconic Therapeutics Company Details
        11.10.2 Iconic Therapeutics Business Overview
        11.10.3 Iconic Therapeutics Age-related Macular Degeneration Introduction
        11.10.4 Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.10.5 Iconic Therapeutics Recent Developments
    11.11 Neurotech Pharmaceuticals
        11.11.1 Neurotech Pharmaceuticals Company Details
        11.11.2 Neurotech Pharmaceuticals Business Overview
        11.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Introduction
        11.11.4 Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.11.5 Neurotech Pharmaceuticals Recent Developments
    11.12 Ohr Pharmaceutical
        11.12.1 Ohr Pharmaceutical Company Details
        11.12.2 Ohr Pharmaceutical Business Overview
        11.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Introduction
        11.12.4 Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2017-2022)
        11.12.5 Ohr Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Age-related Macular Degeneration Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Wet AMD
    Table 3. Key Players of Dry AMD
    Table 4. Global Age-related Macular Degeneration Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Age-related Macular Degeneration Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Age-related Macular Degeneration Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Age-related Macular Degeneration Market Share by Region (2017-2022)
    Table 8. Global Age-related Macular Degeneration Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Age-related Macular Degeneration Market Share by Region (2023-2028)
    Table 10. Age-related Macular Degeneration Market Trends
    Table 11. Age-related Macular Degeneration Market Drivers
    Table 12. Age-related Macular Degeneration Market Challenges
    Table 13. Age-related Macular Degeneration Market Restraints
    Table 14. Global Age-related Macular Degeneration Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Age-related Macular Degeneration Revenue Share by Players (2017-2022)
    Table 16. Global Top Age-related Macular Degeneration by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2021)
    Table 17. Ranking of Global Top Age-related Macular Degeneration Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Age-related Macular Degeneration Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Age-related Macular Degeneration Product Solution and Service
    Table 21. Date of Enter into Age-related Macular Degeneration Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Age-related Macular Degeneration Revenue Market Share by Type (2017-2022)
    Table 25. Global Age-related Macular Degeneration Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Age-related Macular Degeneration Revenue Market Share by Type (2023-2028)
    Table 27. Global Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Age-related Macular Degeneration Revenue Share by Application (2017-2022)
    Table 29. Global Age-related Macular Degeneration Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Age-related Macular Degeneration Revenue Share by Application (2023-2028)
    Table 31. North America Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Age-related Macular Degeneration Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Age-related Macular Degeneration Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Bayer HealthCare Company Details
    Table 62. Bayer HealthCare Business Overview
    Table 63. Bayer HealthCare Age-related Macular Degeneration Product
    Table 64. Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 65. Bayer HealthCare Recent Developments
    Table 66. F. Hoffmann-La Roche Company Details
    Table 67. F. Hoffmann-La Roche Business Overview
    Table 68. F. Hoffmann-La Roche Age-related Macular Degeneration Product
    Table 69. F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 70. F. Hoffmann-La Roche Recent Developments
    Table 71. Novartis Company Details
    Table 72. Novartis Business Overview
    Table 73. Novartis Age-related Macular Degeneration Product
    Table 74. Novartis Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 75. Novartis Recent Developments
    Table 76. Regeneron Pharmaceuticals Company Details
    Table 77. Regeneron Pharmaceuticals Business Overview
    Table 78. Regeneron Pharmaceuticals Age-related Macular Degeneration Product
    Table 79. Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 80. Regeneron Pharmaceuticals Recent Developments
    Table 81. Alcon Company Details
    Table 82. Alcon Business Overview
    Table 83. Alcon Age-related Macular Degeneration Product
    Table 84. Alcon Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 85. Alcon Recent Developments
    Table 86. Allergan Company Details
    Table 87. Allergan Business Overview
    Table 88. Allergan Age-related Macular Degeneration Product
    Table 89. Allergan Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 90. Allergan Recent Developments
    Table 91. Avalanche Company Details
    Table 92. Avalanche Business Overview
    Table 93. Avalanche Age-related Macular Degeneration Product
    Table 94. Avalanche Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 95. Avalanche Recent Developments
    Table 96. Bausch+Lomb Company Details
    Table 97. Bausch+Lomb Business Overview
    Table 98. Bausch+Lomb Age-related Macular Degeneration Product
    Table 99. Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 100. Bausch+Lomb Recent Developments
    Table 101. Gilead Sciences Company Details
    Table 102. Gilead Sciences Business Overview
    Table 103. Gilead Sciences Age-related Macular Degeneration Product
    Table 104. Gilead Sciences Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 105. Gilead Sciences Recent Developments
    Table 106. Iconic Therapeutics Company Details
    Table 107. Iconic Therapeutics Business Overview
    Table 108. Iconic Therapeutics Age-related Macular Degeneration Product
    Table 109. Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 110. Iconic Therapeutics Recent Developments
    Table 111. Neurotech Pharmaceuticals Company Details
    Table 112. Neurotech Pharmaceuticals Business Overview
    Table 113. Neurotech Pharmaceuticals Age-related Macular Degeneration Product
    Table 114. Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 115. Neurotech Pharmaceuticals Recent Developments
    Table 116. Ohr Pharmaceutical Company Details
    Table 117. Ohr Pharmaceutical Business Overview
    Table 118. Ohr Pharmaceutical Age-related Macular Degeneration Product
    Table 119. Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
    Table 120. Ohr Pharmaceutical Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Age-related Macular Degeneration Market Share by Type: 2021 VS 2028
    Figure 2. Wet AMD Features
    Figure 3. Dry AMD Features
    Figure 4. Global Age-related Macular Degeneration Market Share by Application: 2021 VS 2028
    Figure 5. Drugstore Case Studies
    Figure 6. Hospital Case Studies
    Figure 7. Others Case Studies
    Figure 8. Age-related Macular Degeneration Report Years Considered
    Figure 9. Global Age-related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Age-related Macular Degeneration Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Age-related Macular Degeneration Market Share by Region: 2021 VS 2028
    Figure 12. Global Age-related Macular Degeneration Market Share by Players in 2021
    Figure 13. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Age-related Macular Degeneration Revenue in 2021
    Figure 15. North America Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
    Figure 17. North America Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
    Figure 18. North America Age-related Macular Degeneration Market Size Share by Country (2017-2028)
    Figure 19. United States Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Age-related Macular Degeneration Market Size Share by Country (2017-2028)
    Figure 25. Germany Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Age-related Macular Degeneration Market Size Share by Region (2017-2028)
    Figure 35. China Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Age-related Macular Degeneration Market Size Share by Country (2017-2028)
    Figure 45. Mexico Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Age-related Macular Degeneration Market Size Share by Country (2017-2028)
    Figure 51. Turkey Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Bayer HealthCare Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 56. Novartis Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 57. Regeneron Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 58. Alcon Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 59. Allergan Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 60. Avalanche Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 61. Bausch+Lomb Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 62. Gilead Sciences Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 63. Iconic Therapeutics Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 64. Neurotech Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 65. Ohr Pharmaceutical Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical
Frequently Asked Questions
Age-related Macular Degeneration report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Age-related Macular Degeneration report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Age-related Macular Degeneration report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Connected Car

Connected Car market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Aluminum Extrusion

Aluminum Extrusion market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More